Rifapentine
Edina Avdic, Pharm.D.
Pediatric Dosing Author:
Lisa Hutchins, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Treatment of active tuberculosis
(in combination with other anti-tubercular drugs)
in patients ≥ 12 years of age
Treatment of
latent TB
in combination with
isoniazid
in patients ≥ 2 years of age at high risk of progression to TB disease.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.